S100B and Obesity: Indirect evidence regarding S100B points to the involvement of RAGE, the primary receptor of S100B, in the pathophysiology of adipose tissue, essentially indicating that RAGE-mediated adipose tissue inflammation and insulin-signaling are potentially important mechanisms that contribute to the development of obesity-associated insulin resistance [55,56,57].